To the Editor: Response-Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine

Heart Rhythm

Volumn 7, Issue 6, 2010, Pages 863-864

  Estes III, N A Mark ^a   Page, Richard L ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; QUINIDINE;

DECISION MAKING; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG USE; ECONOMIC ASPECT; HEART ARRHYTHMIA; HUMAN; LETTER; PRIORITY JOURNAL;

ANTI-ARRHYTHMIA AGENTS; BRUGADA SYNDROME; EMPIRICISM; HUMANS; QUINIDINE;

EID: 77952545949     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.03.007     Document Type: Letter

References (8)

1. Viskin S, Belhassen B, Wilde A. Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine Heart Rhythm.
2. http://www.hrsonline.org/Policy/DevicesDrugsFDA/Drugs/Ethmozine_discontinued.cfm (accessed February 3, 2010)
3. http://www.hrsonline.org/Policy/DevicesDrugsFDA/Drugs/procanbid_discontinuation.cfm (accessed February 3, 2010)
4. http://www.hrsonline.org/Policy/DevicesDrugsFDA/Drugs/tikosyn_shortage.cfm (accessed February 3, 2010)
5. http://www.hrsonline.org/Policy/DevicesDrugsFDA/Drugs/digitek_recalls_04-29_08.cfm (accessed February 3, 2010)
6. http://www.hrsonline.org/Policy/DevicesDrugsFDA/Drugs/alli_capsules2010.cfm
7. http://www.hrsonline.org/Policy/DevicesDrugsFDA/archives/Isoproterenol-Now-Available.cfm (accessed February 3, 2010)
8. http://www.fda.gov/Drugs/DrugSafety/DrugShortages/default.htm (accessed February 2, 2010)